Translate
Pacira Biosciences, Inc.
About
Pacira Biosciences, Inc. (NASDAQ:PCRX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
Apr 27 2026
Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty
Apr 16 2026
Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026
Apr 13 2026
Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures
Apr 8 2026
Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
Financials
Revenue
$726.41 M
Market Cap
$976.58 M
P/E Ratio
141.88
EPS
0.16